Malignant Bone Marrow Neoplasm — Trials

Malignant Bone Marrow Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,609 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,034
Recruiting: 591
Ph III recruiting: 61
Growth YoY: +8.6%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (799)

clinicaltrialsPublishedShowing 901–902 of 902 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00044733	Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant	completed	Phase 2	38	Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY	1	May 18, 2006	clinicaltrials
NCT00219752	Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years	completed	Phase 2	30	Poitiers University HospitalOTHER	1	Dec 22, 2005	clinicaltrials